Immediate-type infliximab infusion reaction presenting as purpura
نویسندگان
چکیده
منابع مشابه
Leukocyte Adhesion Deficiency Type 1 Presenting as Leukemoid Reaction
The hallmarks of leukocyte adhesion deficiency (LAD) are defects in the leukocyte adhesion process, marked leukocytosis and recurrent infections. These molecular and clinical manifestations result from an impaired step in the inflammatory process, namely, the emigration of leukocytes from the blood vessels to sites of infection, which requires adhesion of leukocytes to the endothelium. Over las...
متن کاملleukocyte adhesion deficiency type 1 presenting as leukemoid reaction
the hallmarks of leukocyte adhesion deficiency (lad) are defects in the leukocyte adhesion process, marked leukocytosis and recurrent infections. these molecular and clinical manifestations result from an impaired step in the inflammatory process, namely, the emigration of leukocytes from the blood vessels to sites of infection, which requires adhesion of leukocytes to the endothelium. over las...
متن کاملLymphoma presenting as Henoch–Schönlein purpura
Department of Medicine, North Shore Hospital, Waitemata District Health Board, Auckland, New Zealand, LabPlus, Auckland, New Zealand, Department of Molecular Medicine and Pathology, Faculty of Medicine and Health Science, University of Auckland, Auckland, New Zealand, Department of Renal Medicine, North Shore Hospital, Waitemata District Health Board, Auckland, New Zealand and Department of Med...
متن کاملHodgkin's disease presenting as "idiopathic" thrombocytopenic purpura.
A case of Hodgkin's disease presenting as idiopathic thrombocytopenic purpura in a 23-year-old male is reported. This is a rare presentation of Hodgkin's disease having been previously described in only two cases.
متن کاملBreast carcinoma presenting as immune thrombocytopenic purpura.
Figure 1. Asprirate of the bone marrow shows a normal-looking megakarocyte and a clump of neoplastic cells (May-Giemsa Grünwald stain; original magnification 40). Thrombocytopenia is a frequent complication of cancer and is a contraindication for aggressive antineoplastic therapy until the etiology of the low platelet count is determined and the clinical situation is successfully addressed. The...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: JAAD Case Reports
سال: 2018
ISSN: 2352-5126
DOI: 10.1016/j.jdcr.2018.05.015